Professor of Medicine, Tulane University

Gastroenterology

Luis A. Balart Jr. is an expert in the field of Gastroenterology. He attended Louisiana State University School of Medicine in New Orleans. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Luis Balart is also published. He has 34 publications published. The lastest publication: "The optimal treatment of patients with bleeding esophageal varices.' He is registered with Medicare.

Publications

---

• Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.
• Persistent Hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.
• Involvement of interleukin-18 in the pathogenesis of human eosinophilic Esophagitis.
• Epidemiology of Metastatic Hepatocellular Carcinoma, A Nationwide Perspective.
• HCV Infection Selectively Impairs Type I but Not Type III IFN Signaling.
• Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection.
• Thyroid storm complicated by fulminant hepatic failure: case report and literature review.
• United States Women Receive More Curative Treatment for Hepatocellular Carcinoma Than Men.
• Prevalence of Corticosteroids Use and Disease Course After Initial Steroid Exposure in Ulcerative Colitis.
• Racial disparity in New Orleans: a faith-based approach to an age-old problem.
• Mastabol induced acute cholestasis: A case report.
• Methotrexate in Ulcerative Colitis: A Nationwide Retrospective Cohort from the Veterans Affairs Health Care System.
• Incidence of liver toxicity in inflammatory bowel Disease patients treated with methotrexate: a meta-analysis of clinical trials.
• Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
• SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.
• Do probiotics have a role in the management of inflammatory bowel Disease?
• Interstitial pneumonitis in the transplant patient: consider sirolimus-associated pulmonary toxicity.
• Best of DDW 2006.
• Diet options of obesity: fad or famous?
• Problems with NASH? HAIR is some help.
• The optimal treatment of patients with bleeding Esophageal varices.
• Safety and efficacy of recombinant factor VIIa in patients with liver Disease undergoing laparoscopic liver biopsy.
• Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.
• Effect of peginterferon alfa-2a on liver histology in chronic Hepatitis C: a meta-analysis of individual patient data.
• Aggressive resection of hepatocellular carcinoma with right atrial involvement.
• Peginterferon α-2a plus ribavirin in Latino and Non-Latino Whites with HCV genotype 1: Histologic outcomes and tolerability from the LATINO Study.
• Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
• Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.
• Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.
• Association of interleukin-1beta gene polymorphisms with preCancerous gastric lesions in African Americans and Caucasians.
• Elevation of serum riboflavin carrier protein in hepatocellular carcinoma.
• Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
• Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis.

Schools

---

• La State Univ Sch Of Med In New Orleans

• Alton Ochsner Med Fndn

• Med Center La New Orleans Lsu

• Naval Reg Med Center

Procedures Preformed

---

• Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
• Endoscopy (Esophagus, Stomach, Small Intestine)
• ERCP (Endoscopic Retrograde Cholangiopancreatography)
• Liver Biopsy

Conditions Treated

---

• Abdominal Pain
• Anemia
• Barrett's Esophagus
• Benign Neoplasm of the Digestive System
• View All

Doctors Specialties

---

• Gastroenterology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Super Doctor

Education

---

• Ochsner Clinic Foundation
• Louisiana State University
• Louisiana State University School of Medicine in New Orleans

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Abdul M. Khan, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth A. Bollinger, MD This Doctor is OpenDoctor Recommended.
	Dr. James W. Smith, MD This Doctor is OpenDoctor Recommended.
	Dr. Chesley Hines Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Jordan J. Karlitz, MD This Doctor is OpenDoctor Recommended.
	Dr. Kaitlin E. Occhipinti, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth Alonso, MD
	Dr. William A. Ferrante, MD This Doctor is OpenDoctor Recommended.
	Dr. Rebekah H Lemann, MD This Doctor is OpenDoctor Recommended.
	Dr. Mainor R. Antillon Galdamez, MD This Doctor is OpenDoctor Recommended.
	Dr. Adrienne A. Arbour, MD
	Dr. Nigel Girgrah, MD This Doctor is OpenDoctor Recommended.
	Dr. Rajesambhaji S. Borade, MD This Doctor is OpenDoctor Recommended.
	Dr. Reinaldo J. Quevedo, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog